# The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion

> **NCT02910076** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 40 (estimated)

## Conditions studied

- Diabetes Type Two

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT02910076
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2018-08
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02910076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02910076, "The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02910076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*